Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2007-11-29

Clinical Trial Update: Clonidine and Left Ventricular Dysfunction

View source ↗

Summary

The clinical trial evaluating clonidine for left ventricular dysfunction sponsored by University Hospital, Strasbourg, has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clonidine (clonidine)

Snippet

Sponsor: University Hospital, Strasbourg, France | Conditions: Ventricular Dysfunction | Status: WITHDRAWN